Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Behçet's disease and cardiovascular involvement.

F Atzeni1, P Sarzi-Puttini, A Doria

  • 1Rheumatology Unit, L Sacco University Hospital, Milan, Italy.

Lupus
|October 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disentangling Sources of Momentum Fluctuations in Xe+Xe and Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Light Long-Lived Particles in pp Collisions at sqrt[s]=13  TeV Using Displaced Vertices in the ATLAS Inner Detector.

Physical review letters·2024
Same author

Search for the Exclusive W Boson Hadronic Decays W^{±}→π^{±}γ, W^{±}→K^{±}γ and W^{±}→ρ^{±}γ with the ATLAS Detector.

Physical review letters·2024
Same author

Determination of the Relative Sign of the Higgs Boson Couplings to W and Z Bosons Using WH Production via Vector-Boson Fusion with the ATLAS Detector.

Physical review letters·2024
Same author

Studies of the Energy Dependence of Diboson Polarization Fractions and the Radiation-Amplitude-Zero Effect in WZ Production with the ATLAS Detector.

Physical review letters·2024
Same author

Combination of Searches for Higgs Boson Pair Production in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2024
Same journal

Association of systemic lupus erythematosus with 90-day readmission following heart failure hospitalization: A national readmission database (NRD) analysis, 2016-2017.

Lupus·2026
Same journal

Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus.

Lupus·2026
Same journal

Giant cell myocarditis in an 18-year-old patient with new-onset systemic lupus erythematosus: A fatal case of rapidly progressing heart failure.

Lupus·2026
Same journal

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research.

Lupus·2026
Same journal

T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus.

Lupus·2026
Same journal

Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis.

Lupus·2026
See all related articles

Behcet's disease (BD) can affect the heart, with cardiovascular manifestations occurring in 7-46% of patients. This review details cardiac involvement in BD, including pathogenic mechanisms and clinical features in Italian patients.

Area of Science:

  • Rheumatology
  • Cardiology
  • Internal Medicine

Background:

  • Behcet's disease (BD) is a multisystemic inflammatory disorder of unknown cause.
  • Characterized by orogenital ulcers, uveitis, and systemic involvement (articular, GI, CNS, vascular).
  • Cardiac involvement in BD is not fully understood, with reported prevalence ranging from 7-46% and significant mortality.

Purpose of the Study:

  • To review pathogenic mechanisms and clinical features of cardiovascular involvement in Behcet's disease.
  • To present data on cardiovascular manifestations in a cohort of Italian BD patients.

Main Methods:

  • Literature review on cardiovascular manifestations in Behcet's disease.
  • Analysis of cardiovascular involvement in a cohort of Italian patients with Behcet's disease.

Related Experiment Videos

Main Results:

  • Cardiovascular manifestations in BD include endocarditis, myocarditis, pericarditis, myocardial infarction, aortic aneurysm, and valvular dysfunction.
  • Mortality can reach up to 20% in BD patients with severe vascular involvement.
  • Specific data from the Italian cohort on cardiac involvement is presented.

Conclusions:

  • Cardiovascular involvement is a serious complication of Behcet's disease with diverse manifestations.
  • Understanding pathogenic mechanisms and clinical presentation is crucial for patient management.
  • Further data collection in patient cohorts is essential to elucidate the full spectrum of cardiac impact in BD.